SOURCE: Rx Safes, Inc.

Rx Safes, Inc.

November 09, 2015 08:30 ET

Rx Safes CEO Lorraine Yarde Interviewed by Leading Investor Relations Site

HENDERSON, NV--(Marketwired - Nov 9, 2015) - Rx Safes, Inc. (OTC PINK: RXSF), the developer of autonomous fingerprint healthcare security products announced today that it's CEO Lorraine Yarde, has been featured in an interview by leading Investor Relations Portal

In light of the impending effectiveness of its previously announced reverse split, Ms. Yarde sits down with John Pentony of to discuss the basis of the Company's rebranding efforts to offer products and solutions for the commercial healthcare market. Ms. Yarde also provides an overview of the Company's new consumer retail partnership, the impetus for the reverse split and her expectations for the coming year.

Ms. Yarde's interview can be heard in its entirety at

"It is extremely important that we reinforce the Company's commitment to providing REAL solutions to address drug theft and diversion in the home and professional healthcare environments. This is a multi-industry, multi-billion dollar problem and we are one of the only companies addressing this through technology. We have a huge opportunity as a public company to bring further attention to this issue and we are looking to continue to grow our product line as well as our position in the public markets," stated Ms. Yarde.

For information and pricing on the Company's products, please contact the Rx Safes, Inc. by email at, by telephone at 1-844 RX SAFES Ext:1, or visit the company's website at

About Rx Safes, Inc.

Rx Safes is an emerging leader in the personal and professional healthcare drug security market. Our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit

Forward-Looking Statements for RXSF:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Like us on Facebook at
Follow us on Twitter at

Contact Information

  • Investor Relations Contact:

    Email: Email Contact
    Telephone: 1-844-RXSAFES Ext 4